May 15 (Bloomberg) -- A Pfizer Inc. unit failed to properly warn a New Jersey woman about the cancer risk of its hormone- replacement drug Provera and should pay $1.5 million in damages, jurors said in the first trial over the menopause treatment.
May 15 (Bloomberg) -- A Pfizer Inc. unit failed to properly warn a New Jersey woman about the cancer risk of its hormone- replacement drug Provera and should pay $1.5 million in damages, jurors said in the first trial over the menopause treatment.
